BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4707508)

  • 1. [Chemical transformations of cystamine in mouse tissues].
    Golubentsev DA; Titov AV
    Vopr Med Khim; 1973; 19(2):177-81. PubMed ID: 4707508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transformation of cystaphos in the mouse organism].
    Titov AV; Golubentsev DA
    Vopr Med Khim; 1971; 17(1):61-5. PubMed ID: 5555146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Species characteristics of cystamine metabolism in mice and rats].
    Titov AV; Golubentsev DA; Mikhaĭlova EG
    Radiobiologiia; 1974; 14(6):907-9. PubMed ID: 4450001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Absorption of cystaphos from the gastrointestinal tract and its excretion with urine].
    Titov AV
    Farmakol Toksikol; 1971; 34(3):330-3. PubMed ID: 5568696
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation of free and bound forms of sulfur-containing protectors in blood and tissues].
    Titov AV; Golubentsev DA; Mordukhovich VV
    Vopr Med Khim; 1969; 15(5):517-21. PubMed ID: 5368089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intracellular distribution of S35 in the liver and spleen in white mice after administration of S-labelled para-aminoethylisothyuronium, cystamine and 5-mercaptopentylamine disulfide].
    Vladimirov VG
    Radiobiologiia; 1967; 7(1):71-5. PubMed ID: 5608541
    [No Abstract]   [Full Text] [Related]  

  • 7. The distribution and metabolism of the radiation protective agent aminopentylaminoethylphosphorothioate in mice.
    Kollmann G; Martin D; Shapiro B
    Radiat Res; 1971 Dec; 48(3):542-50. PubMed ID: 5137463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of pharmacologically active agents on the transformation of cystamine in mouse tissues].
    Tarnopol'skaia LG
    Radiobiologiia; 1982; 22(2):246-50. PubMed ID: 6953525
    [No Abstract]   [Full Text] [Related]  

  • 9. [Distribution in mouse liver and spleen cell organoids of cystamine-S35 and its metabolic products].
    Pavlova LM; Bondarev GN; Sverdlov AG; Grachev SA; Leonova EV
    Radiobiologiia; 1972; 12(5):671-5. PubMed ID: 4660679
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemical state and content of radioprotector in some rat tissues at early time-intervals after cystamine administration].
    Koshcheenko NN; Filippovich IV; Romantsev EF
    Vopr Med Khim; 1970; 16(1):69-72. PubMed ID: 5435390
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of cystamine conversion in the tissues of white mice and rats].
    Tarnopol'skaia LG
    Farmakol Toksikol; 1978; 41(1):93-7. PubMed ID: 624396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of non-protein thiol groups after the administration of cystamine].
    Titov AV; Golubentsev DA; Mordukhovich VV
    Radiobiologiia; 1970; 10(4):606-8. PubMed ID: 5495593
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the radiation protective effects of cystamine and cysteamine on the skin].
    Van Caneghem P
    Strahlentherapie; 1969 Feb; 137(2):231-7. PubMed ID: 5822230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cysteamine content in mice tissues and in cells of Ehrlich's ascitic carcinoma at the period of its maximal radioprotective action].
    Tarasenko AG; Lieh Suan T'u ; Gusareva EV; Graevskiĭ EIa
    Dokl Akad Nauk SSSR; 1968; 178(4):951-4. PubMed ID: 5660467
    [No Abstract]   [Full Text] [Related]  

  • 15. [A comparative study of the intracellular distribution of S35-cystamine in the liver and spleen of white mice and rats].
    Vladimirov VG
    Radiobiologiia; 1968; 8(2):258-61. PubMed ID: 5676554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Absence of mercaptoethylguanidine and guanidoethyldisulfide among the transformation products of 2-aminoethylisothiuronium in organisms and cells].
    Tarasenko AG; Graevskiĭ EIa; Konstantinova MM; Mandrugin AA; Nekrasova IV
    Dokl Akad Nauk SSSR; 1969 Jul; 187(1):203-6. PubMed ID: 5397743
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of endogenous substances in developing a basis for increased radiation resistance. 5. Mechanism of changes in the level of lipid oxidation products in the radiation protective effect].
    Goncharenko EN; Kudriashov IuB; Zhat'kova GS; Samoĭlikova TI
    Radiobiologiia; 1974; 14(2):210-4. PubMed ID: 4832875
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of "biochemical shock". I. The correlation between the accumulation of some thiol radioprotectors in rat tissues and biochemical changes induced by them.
    Filippovich IV; Koshcheenko NN; Romantzev EF
    Biochem Pharmacol; 1970 Sep; 19(9):2533-40. PubMed ID: 5478279
    [No Abstract]   [Full Text] [Related]  

  • 19. [A method of chromatographic determination of beta-mercaptoethylamine in the blood and tissues].
    Titov AV; Mordukhovich VV; Lerner OM
    Vopr Med Khim; 1970; 16(3):329-33. PubMed ID: 5455892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of H3-mexamine in the mouse body and liver cells].
    Pavlova LM; Sverdlov AG; Grachev SA; Bagiian GA
    Radiobiologiia; 1975 MAR-APR; 15(2):306-8. PubMed ID: 1057217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.